Pathophysiology/Complications

Rosiglitazone Improves Insulin Sensitivity and Lowers Blood Pressure in Hypertensive Patients

  1. Annaswamy Raji, MD,
  2. Ellen W. Seely, MD,
  3. Shannon A. Bekins, BA,
  4. Gordon H. Williams, MD and
  5. Donald C. Simonson, MD
  1. From the Endocrine-Hypertension Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
    Diabetes Care 2003 Jan; 26(1): 172-178. https://doi.org/10.2337/diacare.26.1.172

    Article Information

    vol. 26 no. 1 172-178
    DOI 
    https://doi.org/10.2337/diacare.26.1.172
    PubMed 
    12502676
    Published By 
    American Diabetes Association
    Print ISSN 
    0149-5992
    Online ISSN 
    1935-5548
    History 
    • Published in print January 1, 2003.
    Copyright & Usage 
    DIABETES CARE

    Author Information

    1. Annaswamy Raji, MD,
    2. Ellen W. Seely, MD,
    3. Shannon A. Bekins, BA,
    4. Gordon H. Williams, MD and
    5. Donald C. Simonson, MD
    1. From the Endocrine-Hypertension Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
      View Full Text

      Statistics from Altmetric.com

      Article usage

      Article usage: to

      Rendering graph...
      AbstractFullPdf

      Back to top
      Diabetes Care: 26 (1)

      In this Issue

      January 2003, 26(1)
      Sign up to receive current issue alerts
      View Selected Citations (0)
      Print
      Download PDF
      Article Alerts
      Email Article
      Citation Tools
      Add to Selected Citations

      Rosiglitazone Improves Insulin Sensitivity and Lowers Blood Pressure in Hypertensive Patients
      Annaswamy Raji, Ellen W. Seely, Shannon A. Bekins, Gordon H. Williams, Donald C. Simonson
      Diabetes Care Jan 2003, 26 (1) 172-178; DOI: 10.2337/diacare.26.1.172
      del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

      Jump to section